Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Weymouth › NPI 1598870800
Physician

Metro South Pathology, INC.

Metro South Pathology, INC. was paid $362K by Medicaid between Jan 2018 and Nov 2024, across 25 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 83% of everything it billed.

33Billing provider infoMETRO SOUTH PATHOLOGY, INC.
WEYMOUTH, MA 02190
33aNPI1598870800assigned 08/20/2006
28Total paid$362K
24GClaims10,444
24DCodes billed25
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Massachusetts

Rank by total paid#10 of 125
Median peer was paid$22K
This provider vs. median17×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018892$30K
20191,057$39K
2020983$37K
20212,290$59K
20221,510$64K
20232,069$76K
2024incomplete1,643$58K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
88305 Level IV - Surgical pathology, gross and microscopic examination 83% 7,389 7,140 $302K
88307 7.4% 489 479 $27K
86077 5.3% 741 649 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 284 252 $5K
87207 <1% 297 274 $3K
88304 <1% 335 333 $2K
88112 <1% 83 83 $1K
88342 <1% 72 61 $931.51
84484 <1% 61 34 $309.09
82962 <1% 77 25 $258.52
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 147 77 $240.29
80053 Comprehensive metabolic panel <1% 101 67 $221.56
13 more codes
80050 General health panel <1% 12 $188.98
80048 Basic metabolic panel (calcium, ionized) <1% 68 $126.77
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 15 $79.38
83735 <1% 51 $73.70
83036 Hemoglobin; glycosylated (A1C) <1% 17 $48.52
83690 <1% 31 $42.78
85610 <1% 41 $35.26
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 15 $33.48
84100 <1% 22 $24.69
81001 <1% 23 $14.49
81003 <1% 29 $13.95
80061 Lipid panel 0% 13 $0.00
86850 0% 31 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKASIMER, WILLIAM (PRESIDENT)